A Study of CS060380 Tablets in Patients With MASH and Obesity

NCT07466017 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Dysfunction-associated Steatohepatitis (MASH)
Obesity

Interventions

DRUG: semaglutide
DRUG: CS060380
DRUG: Placebo

Sponsor

Cascade Pharmaceuticals, Inc